Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Bristol-Myers, Johnson & Johnson Get in on Europeon Biotech Fund's $95M Raise October 30, 2017 Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data March 2, 2017 Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data March 2, 2017
Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
